Ray Dalio Merck & Co., Inc. Transaction History

Bridgewater Associates, LP

$19.6 Billion
Q1 2024

A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Merck & Co., Inc. stock. As of the latest transaction made, Bridgewater Associates, LP holds 2,090,256 shares of MRK stock, worth $274 Million. This represents 1.41% of its overall portfolio holdings.

Number of Shares

2,090,256

Previous 1,957,062 6.81%

Holding current value

$274 Million

Previous $213 Million 29.27%

% of portfolio

1.41%

Previous 1.2%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$113.24 - $131.95 $15.1 Million - $17.6 Million	133,194 Added 6.81%	2,090,256 $276 Million
Q4 2023 Feb 14, 2024	BUY	$100.18 - $109.02 $33.4 Million - $36.4 Million	333,814 Added 20.56%	1,957,062 $213 Million
Q3 2023 Nov 13, 2023	BUY	$102.95 - $114.33 $27 Million - $30 Million	262,304 Added 19.27%	1,623,248 $167 Million
Q2 2023 Aug 11, 2023	BUY	$108.61 - $118.38 $48.7 Million - $53 Million	447,960 Added 49.07%	1,360,944 $157 Million
Q1 2023 May 12, 2023	SELL	$102.94 - $114.86 $2.14 Million - $2.39 Million	-20,781 Reduced 2.23%	912,984 $97.1 Million

Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $46.5 Million - $59.6 Million	-531,637 Reduced 36.28%	933,765 $104 Million
Q3 2022 Nov 10, 2022	BUY	$84.53 - $94.96 $12.4 Million - $14 Million	147,055 Added 11.15%	1,465,402 $126 Million
Q2 2022 Aug 11, 2022	BUY	$83.49 - $94.64 $44.6 Million - $50.6 Million	534,277 Added 68.14%	1,318,347 $120 Million
Q1 2022 May 13, 2022	BUY	$73.51 - $82.4 $28.9 Million - $32.4 Million	393,728 Added 100.87%	784,070 $64.3 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $18.2 Million - $22.8 Million	251,339 Added 180.82%	390,342 $29.9 Million
Q3 2021 Nov 12, 2021	BUY	$71.68 - $78.83 $4.71 Million - $5.18 Million	65,706 Added 89.64%	139,003 $10.4 Million
Q2 2021 Aug 13, 2021	BUY	$70.31 - $77.77 $5.15 Million - $5.7 Million	73,297 New	73,297 $5.7 Million
Q2 2020 Aug 12, 2020	SELL	$70.42 - $80.13 $3.33 Million - $3.79 Million	-47,304 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$63.36 - $87.82 $3 Million - $4.15 Million	47,304 New	47,304 $3.64 Million
Q4 2019 Feb 13, 2020	SELL	$77.58 - $87.54 $612,183 - $690,778	-7,891 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$76.08 - $82.93 $600,347 - $654,400	7,891 New	7,891 $664,000
Q4 2018 Feb 13, 2019	SELL	$65.24 - $75.71 $7.26 Million - $8.43 Million	-111,299 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$57.69 - $67.84 $4.49 Million - $5.28 Million	-77,790 Reduced 41.14%	111,299 $7.9 Million
Q2 2018 Aug 13, 2018	SELL	$50.83 - $59.72 $351,794 - $413,322	-6,921 Reduced 3.53%	189,089 $0
Q1 2018 May 15, 2018	BUY	$50.96 - $59.23 $2.18 Million - $2.54 Million	42,804 Added 27.94%	196,010 $10.7 Million
Q4 2017 Feb 13, 2018	BUY	$51.62 - $61.64 $7.91 Million - $9.44 Million	153,206	153,206 $8.62 Million

Others Institutions Holding MRK

# of Institutions

3,757

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $332B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track Ray Dalio's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Account